Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders
US11650214B2 · kind B2 · utility
0Cited by
3References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 9, 2020 |
| Grant date | May 16, 2023 |
| Priority date | — |
| Expiry date | Feb 27, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the identification of proteins of the WNT signaling pathway as therapeutic targets of pigmentation disorder and as biomarkers of pigmentation status.The invention in particular relates to products and methods for treating a hypopigmentation disorder.The invention also relates to products and methods for detecting, diagnosing, staging or monitoring the course of hypopigmentation disorder and is particularly suited for human subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.